WPRIM Management System> DCMS> Journal of the Korean Cancer Association> > 29

Volume: 29

1. A Case of Malignant Chondroid Syringoma with Lung Metastasis. Page:1119—1119
2. Primary Squamous Cell Carcinoma of the Breast. Page:1114—1118
3. A Clinical Study on Patients with Chronic Lymphocytic Leukemia. Page:1106—1113
4. Clinical Study of Stage I Renal Cell Carcinoma. Page:1100—1105
5. Transhiatal Esophagectomy Using Laparoscope in Esophageal Cancer. Page:1094—1099
6. Characteristics and Prognosis in Gastric Cancer with Liver Metastasis. Page:1085—1093
7. Clinicopathologic Features and Prognosis of Gastric Remnant Cancer after Partial Gastrectomy for Benign and Malignant Gastric Lesions. Page:1076—1084
8. Clinicopathologic Features, Survival Rates and Prognostic Factors of Gastric Cancer in Young Age Group under 30 Years of Age. Page:1069—1075
9. A Clinical Study of 500 Cases of Breast Cancer. Page:1061—1068
10. Results of Postoperative Radiation Therapy in 77 Patients of Breast Cancer. Page:1049—1060
11. Expression of Rous Sarcoma Virus Enhancer Factor Gene in Human Hepatocellular Carcinoma. Page:547—554
12. Post-operative Adjuvant Chemotherapy with 5-Fluorouracil, Leucovorin, and Mitomycin C (MLF) for Gastric Cancer. Page:791—799
13. Effects of Lovastatin in Combination with 5-FU on Stomach Cancer Cells. Page:785—790
14. The Expression of c-myc and AAT in Gastric Carcinoma. Page:774—784
15. Clinical Significance of Urokinase-type Plasminogen Activator (uPA) Expression from Serum and Tissue of Gastric Cancer Patients. Page:765—773
16. A Study of Retrovirus-mediated p53 Gene Transduction Into Human Gastric Cancer Cell Lines. Page:754—764
17. Reclassification of the Medullary Carcinoma and It's Clinical Characteristics. Page:748—753
18. The Significance of DNA Flow-cytometry in Breast Cancer. Page:738—747
19. Value of Phospholipase C gamma-1, Epidermal Growth Factor Receptor, and Her-2/neu in Human Breast Cancer. Page:724—737
20. Germline Mutations of BRCA1 Gene in Korean Breast and/or Ovarian Cancer Families. Page:713—723
21. Lumpectomy with Axillary Dissection for Breast Cancer. Page:1041—1048
22. Increment of Telomerase Activity with Breast Cancer Progression. Page:1032—1040
23. TGF-beta-1 Expression and p53 Mutation in Non-small Cell Carcinomas of the Lung. Page:1022—1031
24. Combination Chemotherapy with Etoposide, Ifosfamide, and Cisplatin (VIP) in Small Cell Lung Cancer. Page:1011—1021
25. Prognostic Factor Analysis of Small Cell Lung Cancer: Appropriateness of Two Staging System. Page:1000—1010
26. Linear Accelerator-Based Stereotactic Radiosurgery for Acoustic Neurinomas. Page:992—999
27. Prognostic Factors for Local Control and Survival in T1-T2 Glottic Cancer. Page:984—991
28. Differential Mucin Gene Expression Associated with Methotrexate Resistance of Human Colonic Adenocarcinoma Cell Line, HT29. Page:977—983
29. Effects of Lipid Soluble Components of Korean Red Ginseng on Proliferation and Cell Cycle Regulation Factors in Human Melanoma Cell Lines. Page:965—976
30. A Study on the Tropism of Epstein-Barr Virus. Page:954—964
31. Alteration of Oleate-Phospholipase D Activities in Some Cell Lines after Irradiation. Page:944—953
32. Characterization of Apoptotic Human Thymocytes. Page:930—943
33. The Relationship between Radiation-induced Apoptosis and the Expression of Cytokines in the Small Intestine of Rats. Page:921—929
34. Malignant Gastric Tumors Excluding Adenocarcinoma. Page:340—343
35. Comparison of Tropisetron with Ondansetron in the Prevention of Cisplatin-induced Nausea and Vomiting. Page:332—339
36. Combined Therapy of Gene Therapy using the Herpes Simplex Virus Thymidine Kinase, and Retinoic Acid. Page:321—331
37. Role of Cell Surface Mucin on Invasion and Metastasis of HM7 Colon Cancer Cells. Page:309—320
38. Cytogenetic Effects of Radiotherapy on Peripheral Blood Lymphocytes of Cancer Patients. Page:299—308
39. Germline Mutation of Rb1 Gene in Korean Retinoblastoma Patients. Page:291—298
40. A Study on the Loss of Heterozygosity of the p53 Gene in Primary Uterine Cervical Carcinomas. Page:280—290
41. Prognostic Significance of Histologic Features, DNA Content, Expression of Proliferating Cell Nuclear Antigen (PCNA), c-fos Protein and Transforming Growth Factor (TGF)-alpha and -beta in Giant Cell Tumor of Bone. Page:266—279
42. Quantitative Correlation between the Biochemical Markers and The Extent of Metastatic Bone Tumors. Page:257—265
43. Palliative Radiotherapy for Painful Bone Metastases. Page:250—256
44. Expression of DNA Topoisomerase II and P-Glycoprotein in Breast Cancer. Page:242—249
45. Efficiency of Positron Emission Tomography (PET) in Diagnosis of Breast Cancer. Page:235—242
46. Hepatic Intraarterial Chemotherapy in Unresectable Hepatic Metastases of Colorectal Cancer. Page:227—234
47. Studies on the Mechanism of Hypoxic Increase of VEGF Expression in the Hep3B Human Hepatoma Cells. Page:220—226
48. Detection of p53 Gene Mutations in Gastric Cancers: Comparative study of Single Strand Conformational polymorphism migration Technique (SSCP) and Non-Isotopic RNase Cleavage Assay (NIRCA). Page:212—219
49. Midkine Gene Expression in Gastric Cancer Tissues. Page:204—211
50. Prognostic Significance of the Extent of Lymph Node Dissection in Gastric Cancer. Page:198—203
51. Effects of Combination Chemotherapy Depending on The Expression of Neuron Specific Enolase (NSE), P-Glycoprotein (PgP) and Glutathione S-Transferase (GST)-pai in Advanced Non-Small Cell Lung Cancer. Page:189—197
52. A Case of Metastatic Epididymal and the Other Metastatic Testicular Carcinoma from Sigmoid Carcinoma. Page:706—706
53. Stability of Cisplatin and Etoposide in Normal Solution. Page:700—705
54. Effect of Granisetron Plus Dexamethasone in the Prevention of Delayed Nausea and Vomiting. Page:690—699
55. Type IV Collagen and E-cadherin Expression of Progressive Uterine Cervical Epithelial Lesions. Page:681—689
56. Glutathione S-Transferase Polymorphisms and Genetic Susceptibility to Cervical Cancer. Page:673—680
57. Pronostic Value of The Expression of Mutant p53 and EGFR mRNA in Transitional Cell Carcinoma of the Bladder. Page:663—672
58. The Detection of the Heat Production in Breast Cancer. Page:656—662
59. Effect of Paclitaxol, Cisplatin, and 5-Flurouracil Chemotherapy in Advanced Stomach Cancer. Page:648—655
60. Tumor Angiogenesis As a Predictor of Prognosis in Gastric Carcinoma. Page:640—647
61. Effects of Combined Splenectomy with Total Gastrectomy on the Prognosis in Gastric Cancer. Page:632—639
62. Using the Lymph Node Metastasis Prediction Program in Curative Resection of Gastric Cancer. Page:623—631
63. Comparison of Radiation Therapy and Combined Chemotherapy and Radiation Therapy for Locally Advanced Head and Neck Cancer. Page:616—622
64. Phase III Randomized Trial of ACNU in Addition to Surgery and Radiotherapy for Patients with Supratentorial Malignant Gliomas. Page:608—615
65. Study of UV DNA Repair Endonucleases with Respect to Skin Cancers. Page:599—607
66. p53 Gene Mutations in Astrtocytoma Detection by Direct DNA Sequencing. Page:590—598
67. Radiosensitivity in Acquired Cisplatin-Resistant Human Stomach Adenocarcinoma Cells. Page:584—589
68. The Effect of Metallothionein on the Resistance to Cisplatin in Transfected Mouse NIH/3T3 Cells. Page:576—583
69. Limited Cytotoxic Effect of Adenoviral-mediated p53 Gene Transfer in Variable Non-small Cell Lung Cancer (NSCLC) Cell Lines. Page:565—575
70. Effects of Interleukin-2 Transduction into the Human Hepatoma Cell Lines Using Retroviral Vector. Page:555—564
71. A Case of Cryptococcal Meningitis in a Brest Cancer Patient with Liver Metastasis, Suffering from Herpes Zoster. Page:540—540
72. A Case of Pyloric Obstruction Caused by Self-expandable Metallic Stent for Palliation of Malignant Dysphagia. Page:534—539
73. A Case of the Pancreatic Pseudocyst due to Metastatic Malignant Melanoma. Page:528—533
74. A Case of Ovarian Mullerian Mucinous Papillary Cystadenoma of Borderline Malignancy. Page:522—527
75. A Case of Acute Myelogenous Leukemia during Pregnancy. Page:516—521
76. Acute Myeloid Leukemia with Trisomy 9 Following Chemotherapy of Non-Hodgkin's Lymphoma. Page:512—515
77. The Study of Chromosomal Aberration in NSCLC Patients which Developed after Administration of Chemotherapeutic Agents. Page:504—511
78. Morphological Transformation Region II (mtrII) of Human Cytomegalovirus. Page:495—503
79. IMVP-16/Pd (Ifosfamide/Methotrexate/VP-16/Prednisone) Combination Chemotherapy for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma. Page:486—494
80. The Incidence of Epstein-Barr Virus Nuclear Antigen in Sporadic Non-Hodgkin's Lymphomas of Korean. Page:473—485
81. The Patterns of Lateral Neck Node Involvement in Papillary Thyroid Carcinoma. Page:466—472
82. An Immunohistochemical Study of Tumor Angiogenesity and EMA Reactivity in Papillary Thyroid Carcinoma. Page:454—465
83. Immunodetections of the Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinases (TIMP-2) in Prostatic Adenocarcinomas. Page:445—453
84. In Vitro Growth Inhibition of Human Ovarian Cancer Cell Lines by Mitosene Analogues. Page:437—444
85. Cytochrome P450 2E1 Polymorphisms and Genetic Susceptibility to Cervical Cancer. Page:429—436
86. A Clinicopathologic Analysis of Medullary Breast Cancer. Page:422—428
87. A Study of Apoptosis, and bcl-2 and p53 Expressions in Breast Cancer. Page:412—421
88. A Case of Malignant Mesothelioma of the Uterus. Page:362—362
89. Chronic Subdural Hematoma Associated with Dural Metastasis of Gastric Carcinoma. Page:358—361
90. A Case of Primary Splenic Angiosarcoma Associated with Kasabach-Merritt Syndrome. Page:352—357
91. Avascular Necrosis of Bone Complicating Treatment of Malignant Lymphoma: Report of 6 cases. Page:344—351
92. A Case of Solitary Bone Plasmacytoma of the Middle Cranial Fossa. Page:182—182
93. A Case of Cervical Adenocarcinoma with Pulmonary Metastasis Resembling Miliary Tuberculosis. Page:176—181
94. A Case of Head and Neck Cancer Diagnosed In a Systemic Lupus Erythematosus Patient. Page:171—175
95. Clinicopathological Correlation of Bcl-2 and p53 Immunohistochemistry in Breast Cancer. Page:404—411
96. Anti-tumor Effects of Growth Factor Inhibitors and Anti-metastatic Agents in Human Gastric Cancer Cell Lines. Page:391—403
97. Immunoregulatory Effect of Mesima (R) as an Immunotherapeutic Agent in Stage III Gastric Cancer Patients after Radical Gastrectomy. Page:383—390
98. Polymorphism Analysis of Helicobacter pylori Urease A Gene in Gastric Cancer Samples. Page:375—382
99. Significant Correlation of Hepatocyte Growth Factor Level with Progression of Gastric Adenocarcinoma. Page:367—374
100. Effect of Cytosine Arabinoside and Daunorubicin (AD) Combination Chemotherapy in Acute Myelogenous Leukemia. Page:160—170
101. VACOP-B (Etoposide/Doxorubicin/Cyclophosphamide/Vincristine/Prednisolone/Bleomycin) Combination Chemotherapy for the Treatment of Intermediate and High Grade Non-Hodgkin's Lymphoma. Page:146—159
102. Clinicopathologic Comparison of Intermediate or High Grade Peripheral T-Cell Lymphoma with Diffuse B-Cell Lymphoma. Page:136—145
103. Chemotherapy of Advanced Soft Tissue Sarcoma with Etoposide, Ifosfamide, and Cisplatin (VIP). Page:128—135
104. Expression of Gonadotropin-Releasing Hormone Receptor in Human Uterine Endometrial and Ovarian Tissues. Page:117—127
105. The Results of Postoperative Radiation Therapy in the Rectal Cancer. Page:111—116
106. A Phase II Study of AP (Doxorubicin, Cisplatin) Chemotherapy in Patients with Advanced Hepatocellular Carcinoma. Page:103—110
107. Immunohistochemical Analysis of the Expression of Cathepsin D in Human Gastric Adenocarninoma. Page:93—102
108. Synchronous Expression of Circulating Intercellular Adhesion Molecule-1 (ICAM-1) and Vascular Cell Adhesion Molecule-1 (VCAM-1) During Gastric Cancer Progression. Page:81—92
109. Evaluation of Biologic Phenotype by Midkine Gene Expression in Gastric Cancer as a Target for Biotherapy. Page:69—80
110. Quantitative Analysis of Metastatic Lymph Nodes after Curative Surgery in Gastric Cancer. Page:62—68
111. Relation Between Hormone Receptor (Enzyme-Immunoassay and Immunohistochemistry), Histologic Grade and Mammographic Findings in Patients with Primary Breast Cancer. Page:53—61
112. 5-Fluorouracil, Leucovorin, Ifosfamide and Cisplatin (FLIP) Combination Chemotherapy for Adevanced Non-Small Cell Lung Cancer. Page:46—52
113. Effect of FCL (5-FU, carboplatin, leucovorin) Chemotherapy in Advanced Head and Neck Cancer. Page:38—45
114. Anti-tumor Effect of the Complex of Acriflavine and Guanosine (AG60). Page:29—37
115. Antitumor Effect of Methotrexate in SCID Mice with Human Leukemia CCRF-CEM Cell Line. Page:19—28
116. Expression and Intracellular Localization of Hepatitis C Viral Core Protein in Human Hepatoma Cell Line Transfected with Viral cDNA. Page:11—18
117. Comparison of Efficiency of Infection of Human Cancer Cell Lines Via Retroviral Vector System. Page:1—10
118. A Report of Hepatocellular Carcinoma with Renal Metastasis. Page:914—914
119. Four Cases of Typhlitis, Developed in Neutropenic State and Treated with Medical Conservative Management. Page:906—913
120. A Clinical Analysis of Primary Small Bowel Cancer. Page:899—905
121. A Phase I/II Trial of DA3030 in Chemotherapy Induced Neutropenia. Page:886—898
122. A Preliminary Report of Busulfan, Melphalan and Thiotepa or TBI-containing Bi-alkylator Chemotherapy as a Preparative Regimen for Allogeneic Bone Marrow Transplantation in Refractory or Relapsed Acute Leukemias. Page:874—885
123. Immunohistochemical Study on Expression of the p53 Protein in Medulloblastoma/PNET. Page:867—873
124. Significance of Epstein-Barr Virus Detection in non-Hodgkin's Lymphoma in Korea. Page:851—866
125. Evaluation of Staging with MR Imaging in the Uterine Cervical Cancer. Page:842—850
126. The Results of Radiation Therapy in Patients with Cancer of the Esophagus. Page:832—841
127. Age-related Clinical Characteristics and Outcome of Hepatic Resection Therapy in Hepatocellular Carcinoma Patients. Page:825—831
128. Evaulation of Angiogenesis and Matrix Metalloproteinase as Prognostic Markers in Squamous Cell Carcinoma of the Lung. Page:816—824
129. The Effect of Neoadjuvant Chemotherapy with 5-Fluorouracil (5-FU), Vinblastine and Cisplatin (FVP) for Stage III Non-Small Cell Lung Cancer (NSCLC). Page:807—815
130. The Effects of Mesima-Ex, the Immunomodulator in Curatively Resected Gastric Cancer. Page:800—806